Press Release: Interpretation of biomedical statistics and principles of evidence-based medicine are the top two general curriculum subjects that best prepare student pharmacists for the Academy of Managed Care Pharmacy (AMCP) Foundation Annual Pharmacy & Therapeutics (P&T) Competition.
The Academy of Managed Care Pharmacy (AMCP) believes that abuse-deterrent opioid analgesic drug products should be used in a clinically appropriate manner; however, we are opposed to Sub. H.B. No. 248 as it requires special consideration for this class of drugs.
Press Release: Seniors with multiple chronic illnesses who had medications delivered to their homes were more likely to adhere to those therapies than individuals who used retail pharmacies.
The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to submit comments for the record on the hearing titled “The Obama Administration’s Medicare Drug Experiment: The Patient and Doctor Perspective” scheduled for May 17, 2016.
Press Release: The Academy of Managed Care Pharmacy (AMCP) is pleased to announce the release of Version 4.0 of the AMCP Format for Formulary Submissions, which includes new guidance on emerging health care issues, such as biosimilars and comparative effectiveness research.
AMCP webinar that reviewed what Systematized Nomenclature of Medicine — Clinical Terms (SNOMED-CT) codes are, why they matter, how they impact managed care pharmacy, and AMCP’s collaboration with other stakeholders to facilitate adoption.
AMCP CEO Blog: New&Views announces a new monthly column by CEO Susan A. Cantrell, RPh, CAE, on breaking news and critical issues. Her first column presents her recent address―her first to the membership―at AMCP’s recent Annual Meeting.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare and Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (CMMI) for the opportunity to provide comments in response to the proposed rule titled “Medicare Program; Part B Drug Payment Model (CMS1670-P)” published in the Federal Register on March 11, 2016.
AMCP webinar that provided an overview of key updates to the Format, Version 4.0, including new guidance related to emerging special topic considerations such as biosimilars, specialty drugs, and companion diagnostic tests.